{"id":"W2981212934","doi":"10.1016/j.eururo.2019.09.024","title":"Safety and Efficacy of Mirabegron: Analysis of a Large Integrated Clinical Trial Database of Patients with Overactive Bladder Receiving Mirabegron, Antimuscarinics, or Placebo","year":2019,"lang":"en","type":"article","venue":"European Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"Astellas Foundation for Research on Metabolic Disorders; Astellas Pharma Europe; Astellas Pharma","keywords":"Mirabegron; Medicine; Overactive bladder; Tolterodine; Nocturia; Solifenacin; Urology; Placebo; Adverse effect; Internal medicine; Urination; Clinical trial; Urinary system","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001891694,0.0001972941,0.001114485,0.0003972533,0.00002860931,0.000004390638,0.0001685417,0.00009163962,0.0009050617],"category_scores_gemma":[0.00106975,0.0001331739,0.0001686146,0.0007098047,0.0003085143,0.00009002625,0.0002385187,0.0005001949,0.00001260488],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001396368,"about_ca_system_score_gemma":0.0001834119,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005490088,"about_ca_topic_score_gemma":0.00003568018,"domain_scores_codex":[0.9963819,0.00146108,0.001005335,0.0004990299,0.000339311,0.0003133225],"domain_scores_gemma":[0.9966195,0.001707136,0.00050461,0.0006355759,0.0003890151,0.0001441925],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.465429,0.002454859,0.5240641,0.0001202308,0.003682788,0.00005695796,0.0007658651,0.00001545239,0.0002175811,0.00002095283,0.0001875668,0.002984557],"study_design_scores_gemma":[0.09098237,0.01490982,0.8885847,0.00005494781,0.001755131,0.000004602717,0.0001198892,0.0005511538,0.00007207049,5.89729e-7,0.00283715,0.0001275224],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9957018,0.00009713581,0.0001525085,0.00007947135,0.00009679369,0.001010937,0.0004078837,0.0000134067,0.002440009],"genre_scores_gemma":[0.9983923,0.0002353638,0.0003018655,0.00009172231,0.00003911798,0.000001550643,0.0005719764,0.00003545288,0.0003305786],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3744467,"threshold_uncertainty_score":0.9909791,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03355257858904147,"score_gpt":0.3502665604275806,"score_spread":0.3167139818385392,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}